The impact of pharmacist interventions on quality of life in patients with hypertension

International Journal of Pharmaceutical Sciences Review and Research

Volumn 5, Issue 3, 2010, Pages 172-176

  Shahina, P T ^a   Revikumar, K G ^a   Krishnan, R ^b   Jaleel, V A ^b   Shini, V K ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

^b MES Medical College   (India)

Author keywords

Blood pressure; Hypertension; Pharmacist interventions; Quality of life

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; ATTITUDE TO HEALTH; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INTERVENTION STUDY; LIFESTYLE MODIFICATION; MALE; OUTCOME ASSESSMENT; PATIENT CARE PLANNING; PATIENT COMPLIANCE; PATIENT COUNSELING; PHARMACIST ATTITUDE; QUALITY OF LIFE INDEX; SHORT FORM 36; TEACHING HOSPITAL; TELEMONITORING; TERTIARY HEALTH CARE; TOTAL QUALITY MANAGEMENT;

EID: 79952046995     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365: 217-223.
2. Singh RB, Suh IL, Singh VP, et al. Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J Hum Hypertens. 2000; 14:749-763.
3. Yusuf S, Reddy S, Ounpuu S, Anand S. Global Burden of Cardiovascular Diseases: Part I: General Considerations, the Epidemiologic Transition, Risk Factors, and Impact of Urbanization. Circulation. 2001; 104: 2746-2753.
4. Palaian S, Prabhu M, Shankar PR. Patient Counseling By Pharmacist -A Focus on Chronic Illness. Pak. J. Pharm. Sci. 2006; 19(1): 62-65.
5. Testa MA, Simonson DC. Assessment of quality-oflife outcomes.N Engl J Med. 1996; 334: 835-840.
6. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group Psychol Med. 1998; 28 (3): 551-8.
7. Ogunlana MO, Adedokun B, Dairo MD, Odunaiya NA. Profile and predictor of health-related quality of life among hypertensive patients in south-western Nigeria. BMC Cardiovascular Disorder. 2009; 9:25.
8. Cavalcante MA, Bombig MTN, Filho BL, Carvalho ACC, Paola AAV, Povao R et al. Quality of Life of Hypertensive Patients Treated at an Outpatient Clinic. Arq Bras Cardiol. 2007; 89(4):245-50.
9. Wilson IR, Cleary PD. Linking Clinical Variables with Health related Quality of life: a conceptual model of patient's outcomes. JAMA 1995; 273:59-65.
10. Mena-Martin FJM, Martin-Escudero JC, Simal-Blanco F, Carretero-Ares JL, Arzua-Mouronte D, Herreros- Fernandez V: Health-related quality of life of subjects with known and unknown hypertension: results from the population-based Hortega study. J Hypertens. 200321(7):1283-1289.
11. Klocek M, Kawecka-Jaszcz K: Quality of life in patients with essential arterial hypertension. Part I: The effect of socio-demographic factors Przegl Lek. 2003; 60(2):92-100.
12. Li W, Liu L, Puente JG, et al. Hypertension and health-related quality of life: an epidemiological study in patients attending hospital clinics in China. J Hypertens 2005; 23(9):1635-6.
13. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980; 2(6):757-764.
14. Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009; 169(21):1996-2002.
15. Roumie CL, Elasy TA, Greevy R, et al. Improving Blood Pressure Control through Provider Education, Provider Alerts, and Patient Education. Ann Intern Med. 2006; 145:165-175.
16. Bosworth HB, Olsen MK, Grubber JM, et al. Two Self-management Interventions to Improve Hypertension Control. Ann Intern Med. 2009; 151: 687-695.
17. Palanisamy S, Sumathy A. Intervention to improve patient adherence with Antihypertensive Medications at a tertiary care teaching hospital. Int.J. PharmTech Res. 2009; 1(2): 369-374.
18. Lyra Jr DP, Kheir N, Abriata JP, Rocha CE, Santos CB, Pelá IR. Impact of Pharmaceutical Care interventions in the identification and resolution of drug-related problems and on quality of life in a group of elderly outpatients in Ribeirão Preto (SP), Brazil. Ther Clin Risk Manag. 2007; 3(6): 989-998.
19. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365: 217-223.
20. Singh RB, Suh IL, Singh VP, et al. Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J Hum Hypertens. 2000; 14:749-763.
21. Yusuf S, Reddy S, Ounpuu S, Anand S. Global Burden of Cardiovascular Diseases: Part I: General Considerations, the Epidemiologic Transition, Risk Factors, and Impact of Urbanization. Circulation. 2001; 104: 2746-2753.
22. Palaian S, Prabhu M, Shankar PR. Patient Counseling By Pharmacist -A Focus on Chronic Illness. Pak. J. Pharm. Sci. 2006; 19(1): 62-65.
23. Testa MA, Simonson DC. Assessment of quality-oflife outcomes.N Engl J Med. 1996; 334: 835-840.
24. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group Psychol Med. 1998; 28 (3): 551-8.
25. Ogunlana MO, Adedokun B, Dairo MD, Odunaiya NA. Profile and predictor of health-related quality of life among hypertensive patients in south-western Nigeria. BMC Cardiovascular Disorder. 2009; 9:25.
26. Cavalcante MA, Bombig MTN, Filho BL, Carvalho ACC, Paola AAV, Povao R et al. Quality of Life of Hypertensive Patients Treated at an Outpatient Clinic. Arq Bras Cardiol. 2007; 89(4):245-50.
27. Wilson IR, Cleary PD. Linking Clinical Variables with Health related Quality of life: a conceptual model of patient's outcomes. JAMA 1995; 273:59-65.
28. Mena-Martin FJM, Martin-Escudero JC, Simal-Blanco F, Carretero-Ares JL, Arzua-Mouronte D, Herreros- Fernandez V: Health-related quality of life of subjects with known and unknown hypertension: results from the population-based Hortega study. J Hypertens. 200321(7):1283-1289.
29. Klocek M, Kawecka-Jaszcz K: Quality of life in patients with essential arterial hypertension. Part I: The effect of socio-demographic factors Przegl Lek. 2003; 60(2):92-100.
30. Li W, Liu L, Puente JG, et al. Hypertension and health-related quality of life: an epidemiological study in patients attending hospital clinics in China. J Hypertens 2005; 23(9):1635-6.
31. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980; 2(6):757-764.
32. Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009; 169(21):1996-2002.
33. Roumie CL, Elasy TA, Greevy R, et al. Improving Blood Pressure Control through Provider Education, Provider Alerts, and Patient Education. Ann Intern Med. 2006; 145:165-175.
34. Bosworth HB, Olsen MK, Grubber JM, et al. Two Self-management Interventions to Improve Hypertension Control. Ann Intern Med. 2009; 151: 687-695.
35. Palanisamy S, Sumathy A. Intervention to improve patient adherence with Antihypertensive Medications at a tertiary care teaching hospital. Int.J. PharmTech Res. 2009; 1(2): 369-374.
36. Lyra Jr DP, Kheir N, Abriata JP, Rocha CE, Santos CB, Pelá IR. Impact of Pharmaceutical Care interventions in the identification and resolution of drug-related problems and on quality of life in a group of elderly outpatients in Ribeirão Preto (SP), Brazil. Ther Clin Risk Manag. 2007; 3(6): 989-998.